TransMedics launches CHOPS device to improve organ preservation and support clinical trials for heart and lung transplants.

TransMedics Group introduced the Controlled Hypothermic Organ Preservation System (CHOPS), a new device designed to provide stable, controlled cooling for donor organs. This innovation aims to enhance enrollment in the control arms of ongoing clinical trials for heart and lung transplants, comparing CHOPS to existing static cold storage methods. The device is expected to be FDA-regulated and could expand TransMedics' product offerings if approved. This development supports the company's goal of improving organ transplant outcomes through advanced preservation technology and rigorous clinical evidence.